Page 68 - Read Online

46. Black PC, Shetty A, Brown GA, Esparza-Coss E, Metwalli AR, 49. Alunad 1 Sansom OJ Leung HY. Exploring molecular genetics of
Agarwal PK, McConkey DJ, Hazle JD, Dinney CP. Validating bladder bladder cancer: lessons learned from mouse models. Dis Model Mech
cancer xenograft bioluminescence with magnetic resonance imaging: 2012;5:323-32.
the significance of hypoxia and necrosis. BJU Int 2010;106:1799-804. 50. Pilon-Thomas S, Mackay A, Vohra N, Mulé JJ. Blockade of
47. Hadaschik BA, Black PC, Sea JC, Metwalli AR, Fazli L, Dinney CP, programmed death ligand 1 enhances the therapeutic efficacy
Gleave ME, So AI. A validated mouse model for orthotopic bladder
cancer using transurethral tumour inoculation and bioluminescence of combination immunotherapy against melanoma. J Imrmmol
imaging. BJU Int 2007;100:1377-84. 2010;184:3442-9.
48. Voskoglou-Nomikos T, Pater JL, Seymour L. Clinical predictive 51. Fu CL, Odegaard JI, Herbert DR, Hsieh MH. A novel mouse model
value of the in vitro cell line, human xenograft, and mouse allograft of Schistosoma haematobium egg-induced immunopathology. PLoS
preclinical cancer models. Clin Cancer Res 2003;9:4227-39. Pathog 2012;8:el002605.

58
Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ Issue 2 ¦ February 29, 2016 ¦